Related Experiment Videos
Motor activation time in Parkinson's disease
M J Segura1, J A Bueri, C N Gandolfo
1División Neurología, Hospital Ramos Mejía, Buenos Aires, Argentina.
Medicina
|January 1, 1995
Summary
Parkinson's disease patients show prolonged motor activation time (MAT), indicating delayed intracerebral processing. This slowing is linked to dopamine dysfunction in movement initiation, not cognitive changes.
Area of Science:
- Neuroscience
- Neurology
- Movement Disorders
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting motor function.
- Understanding the precise timing of intracerebral processing delays in PD is crucial for diagnosis and treatment.
- Motor activation time (MAT) offers a potential metric for assessing these delays.
Purpose of the Study:
- To investigate motor activation time (MAT) in Parkinson's disease (PD) patients compared to healthy controls.
- To determine if dopaminergic medication affects MAT in PD patients.
- To explore the relationship between MAT and cognitive function (P3 event-related potential) in PD.
Main Methods:
- MAT was calculated by subtracting sensory and motor evoked potentials from premotor reaction time (RT).
- MAT was assessed in 17 PD patients and 7 age-matched healthy volunteers.
- MAT and auditory P3 event-related potentials were measured in 9 PD patients on and off antiparkinsonian treatment.
Main Results:
- PD patients exhibited significantly prolonged MAT compared to healthy volunteers (p < 0.02).
- Withdrawal from antiparkinsonian medication led to significant MAT slowing (p < 0.01) in PD patients.
- No significant changes in P3 latency or amplitude were observed during medication withdrawal.
Conclusions:
- Prolonged MAT in PD suggests impaired dopaminergic mechanisms in motor initiation.
- MAT slowing in PD is independent of changes in arousal or cognitive state.
- MAT serves as a sensitive indicator of dopaminergic dysfunction in the motor system.